aTyr Pharma | LIFE - Current Liabilities

Stock Price
0.50
Daily Change
-0.06 -10.00%
Monthly
-39.31%
Yearly
-84.59%
Q2 Forecast
0.93

aTyr Pharma reported $11.7M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Ardelyx USD 109.57M 20.96M Mar/2026
aTyr Pharma USD 11.7M 101.49M Mar/2026
Biogen USD 3B 350.5M Mar/2026
Bristol-Myers Squibb USD 19.16B 4.26B Mar/2026
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.57M 2.29M Dec/2025
CSL USD 4.61B 207M Dec/2025
Curis USD 14.08M 5.3M Dec/2025
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
Grifols EUR 2.37B 156.97M Dec/2025
Lakefront Biotherapeutics EUR 100.42M 52.44M Mar/2026
Novartis USD 31.37B 4.1B Mar/2026
Roche Holding CHF 28B 421M Dec/2025
United Therapeutics USD 599.1M 38.5M Mar/2026
Xoma USD 28.3M 6.81M Sep/2025